TLDR
- Shares of Northrop Grumman (NOC) plunged to a 52-week low of $470.06 during trading before settling near $476.45, marking approximately a 1% decline.
- RBC Capital Markets lowered its rating from Outperform to Sector Perform while reducing the price target from $640 down to $525.
- Wall Street maintains a consensus “Moderate Buy” recommendation with a mean price target of $647.57.
- Second-quarter results exceeded projections with adjusted earnings per share of $7.68 compared to the $6.82 consensus, while sales climbed 5% to $10.88 billion.
- RBC highlighted concerns about decelerating defense budget expansion post-fiscal 2027 and minimal international revenue opportunities.
Shares of Northrop Grumman (NOC) sank to their lowest point in a year this week. The defense contractor’s stock bottomed at $470.06 intraday before finishing the session near $476.45, representing about a 1% loss.
Northrop Grumman Corporation, NOC
The decline followed a ratings change from RBC Capital Markets, which downgraded the aerospace and defense company. RBC shifted its stance from Outperform to Sector Perform.
The investment firm simultaneously reduced its price objective on NOC shares. The revised target stands at $525, representing an $115 reduction from the previous $640 mark.
In a client note, analyst Ken Herbert outlined the rationale behind the rating change. He projects approximately 6% yearly revenue expansion from 2026 through 2028, characterizing this as an optimistic scenario comparable to industry competitors.
What’s Driving the Downgrade
Herbert cited the company’s minimal international market presence as a significant weakness. He also highlighted anticipated deceleration in budget increases beyond fiscal year 2027, which could restrict the stock’s appreciation potential.
Boeing secured the F/A-XX fighter jet program recently. Herbert observed that market participants hadn’t anticipated Northrop winning that competition, so the outcome wasn’t a primary factor in the downgrade.
Rather, RBC believes future top-line expansion depends heavily on several critical initiatives. Among these are the B-21 Raider bomber, aerospace programs, and possibly solid rocket motor projects.
Each initiative would require substantial capital investment to generate that anticipated growth. RBC’s financial model incorporates only modest single-digit real increases in defense appropriations from 2028 through 2031.
The firm cautioned about an increasing possibility of budget “crowding out” throughout that period. Herbert emphasized that essential programs should maintain funding support, though he identifies growing risk to the F-35 initiative, which represents roughly 10% of total revenue.
Share repurchase strategy also factored into the analysis. Herbert observed that Northrop eliminated half its outstanding shares between 2007 and 2017, and reduced buyback activity in coming years could negatively impact investor sentiment and per-share earnings progression.
Regarding the B-21 bomber program, RBC anticipates the official order quantity will expand to at least 150 aircraft as operational requirements broaden. However, the analyst continues to view this program as temporarily pressuring profitability metrics.
The Numbers Behind the Stock
Notwithstanding the downgrade, the majority of Wall Street analysts maintain bullish views on NOC. The equity holds a consensus “Moderate Buy” recommendation, accompanied by a mean price objective of $647.57, significantly above present trading levels.
Among covering analysts, two assign Strong Buy ratings, ten recommend Buy, and nine suggest Hold. This reflects considerable diversity of perspectives following recent adjustments to price targets.
The company’s most recent quarterly disclosure, issued July 21st, surpassed Wall Street expectations. Northrop delivered adjusted earnings per share of $7.68 versus the consensus estimate of $6.82.
Quarterly revenue totaled $10.88 billion, representing 5% year-over-year growth and exceeding the $10.80 billion projection. Nevertheless, earnings per share declined from $8.15 in the comparable prior-year period.
Management has issued full-year 2026 EPS guidance ranging from $28.60 to $29.10. Current analyst consensus forecasts $28.97 EPS for the fiscal year, positioned at the midpoint of company guidance.
The corporation also distributes a quarterly dividend of $2.47 per share, translating to an annualized yield of approximately 2.1%. The stock’s 50-day moving average stands at $538.98, while the 200-day moving average registers $568.95, both substantially above current price levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
